` EKF (EKF Diagnostics Holdings PLC) vs FTSE All Share Index Comparison - Alpha Spread

EKF
vs
F
FTSE All Share Index

Over the past 12 months, EKF has outperformed FTSE All Share Index, delivering a return of -1% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
EKF vs FTSE All Share Index

Loading
EKF
FTSE All Share Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
EKF vs FTSE All Share Index

Loading
EKF
FTSE All Share Index
Difference
www.alphaspread.com

Performance By Year
EKF vs FTSE All Share Index

Loading
EKF
FTSE All Share Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
EKF Diagnostics Holdings PLC vs Peers

FTSE All Share Index
EKF
ABT
ISRG
BSX
SYK
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

EKF Diagnostics Holdings PLC
Glance View

Market Cap
111.8m GBX
Industry
Health Care

EKF Diagnostics Holdings Plc is a vitro diagnostics company, which designs and manufactures diagnostic equipment for use within point-of-care settings. The company is headquartered in Penarth, South Glamorgan. The company went IPO on 2002-06-05. The firm's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. Its Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen, Quo-Lab A1c, UltraCrit, DiaSpect, HemataStat II and Creamatocrit Plus. The company operates in Germany, the United States, Russia and the United Kingdom.

EKF Intrinsic Value
30.75 GBX
Undervaluation 19%
Intrinsic Value
Price
Back to Top